drugset / Trial / NCT00108537

Non-Nicotine Agents for Smoking Cessation

NCT00108537 ↗

RandomizedOpen-labelTreatment

Summary

The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.

Timeline

Start
2003-10
Primary completion
—
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule — —
Subject Nicotine Unknown — Intravenous

Indications